Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Skye Bioscience, Inc. Director's Dealing 2015

Apr 16, 2015

34097_dirs_2015-04-16_724a974f-244b-46d6-b6ed-9a7dd8dd1e15.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2015-04-03

Reporting Person: Squires Richard D. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1485000 Direct
Common Stock 15000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Common Stock Warrant (right to buy) $1 2019-06-04 Common Stock (371250) Direct
Common Stock Warrant (right to buy) $1 2019-06-04 Common Stock (3750) Indirect

Footnotes

F1: Represents shares of Common Stock directly owned by RS Holdings, Inc.

F2: Represents shares of Common Stock Warrants directly owned by RS Holdings, Inc.

F3: Mr. Squires disclaims beneficial ownership of any securities directly owned by RS Holdings, Inc. reported herein except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all such shares for purposes of Section 16 or for any other purpose.